← Back
$SLS All transactions

SELLAS Life Sciences Group, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$101K

Shares

63,400

Price

$2

Filed

Nov 21

Why this score? (8/10)
  • Open market buy (+3)
  • % of holdings >= 50% (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Kalin Katherine Bach

Title

CIK

0001832671

Roles

Director

Transaction Details

Transaction Date

2025-11-19

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

104,400

Footnotes

The price reflects the weighted average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $1.555 to $1.625 per share. Ms. Kalin undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.

Filing Info

Accession No.

0001104659-25-114806

Form Type

4

Issuer CIK

0001390478

Kalin Katherine Bach's History

Date Ticker Type Value
2026-01-07 SLS A $0
2025-11-19 SLS $101K
2025-05-22 SLS $36K

Other Insiders at SLS (90d)

No other insider activity at this issuer in the last 90 days.